alprenolol has been researched along with Coronary Disease in 16 studies
Alprenolol: One of the ADRENERGIC BETA-ANTAGONISTS used as an antihypertensive, anti-anginal, and anti-arrhythmic agent.
alprenolol : A secondary alcohol that is propan-2-ol substituted by a 2-allylphenoxy group at position 1 and an isopropylamino group at position 3. It is a beta-adrenergic antagonist used as a antihypertensive, anti-arrhythmia and a sympatholytic agent.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In 14 patients with coronary heart disease the effect of long-term treatment (mean 16 months, range 12-33) with alprenolol on platelet function and fibrinolytic activity was studied." | 9.05 | Effect of long-term beta-blockade with alprenolol on platelet function and fibrinolytic activity in patients with coronary heart disease. ( Dalsgaard-Nielsen, J; Gormsen, J; Jürgensen, HJ; Kjøller, E, 1981) |
| "The effects of nadolol on experimental arrhythmias were investigated and compared with those of propranolol and alprenolol." | 7.67 | Anti-arrhythmic effect of nadolol in experimental arrhythmias: comparison with propranolol and alprenolol. ( Hashimoto, H; Nakashima, M; Oguro, K; Sogabe, K; Takiguchi, Y, 1985) |
| "In 14 patients with coronary heart disease the effect of long-term treatment (mean 16 months, range 12-33) with alprenolol on platelet function and fibrinolytic activity was studied." | 5.05 | Effect of long-term beta-blockade with alprenolol on platelet function and fibrinolytic activity in patients with coronary heart disease. ( Dalsgaard-Nielsen, J; Gormsen, J; Jürgensen, HJ; Kjøller, E, 1981) |
| "The effects of nadolol on experimental arrhythmias were investigated and compared with those of propranolol and alprenolol." | 3.67 | Anti-arrhythmic effect of nadolol in experimental arrhythmias: comparison with propranolol and alprenolol. ( Hashimoto, H; Nakashima, M; Oguro, K; Sogabe, K; Takiguchi, Y, 1985) |
| "The author describes the notions that led to initiation of controlled trials of long-term medication with antiarrhythmic drugs following myocardial infarction, and reviews reports of controlled trials with diphenylhydantoin, alprenolol, and procaine amide." | 3.65 | Arrhythmia prophylaxis: Long-term suppressive medication. ( Lovell, RR, 1975) |
| "The effect is critically reviewed of chronic administration of beta-adrenoreceptor antagonists on morbidity and mortality in angina pectoris and myocardial infarction." | 1.26 | The effect of beta-adrenoreceptive antagonists on the morbidity and mortality in cardiovascular disease. ( Fitzgerald, JD, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (93.75) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Callaerts-Vegh, Z | 1 |
| Evans, KL | 1 |
| Shipley, GL | 1 |
| Davies, PJ | 1 |
| Cuba, DL | 1 |
| Gurji, HA | 1 |
| Giles, H | 1 |
| Bond, RA | 1 |
| Johansson, SR | 1 |
| McCall, M | 1 |
| Wilhelmsson, C | 1 |
| Vedin, JA | 1 |
| Moses, JW | 1 |
| Borer, JS | 1 |
| Hjalmarson, A | 1 |
| Jürgensen, HJ | 2 |
| Nielsen, JD | 1 |
| Gormsen, J | 2 |
| Kjøller, E | 2 |
| Frishman, WH | 1 |
| Furberg, CD | 1 |
| Friedewald, WT | 1 |
| Rasmussen, SL | 1 |
| Pedersen, F | 1 |
| Nielsen, PB | 1 |
| Dalsgaard-Nielsen, J | 1 |
| Guse, PA | 1 |
| Gaide, MS | 1 |
| Myerburg, RJ | 1 |
| Epstein, K | 1 |
| Gelband, H | 1 |
| Bassett, AL | 1 |
| Storstein, L | 1 |
| Fitzgerald, JD | 1 |
| Tannenbaum, H | 1 |
| Lovell, RR | 1 |
| Dintenfass, L | 1 |
| Lake, R | 1 |
| Bailey, IK | 1 |
| Anderson, SD | 1 |
| Rozea, PJ | 1 |
| Bernstein, L | 1 |
| Nyberg, G | 1 |
| Korner, PI | 1 |
| Nakashima, M | 1 |
| Takiguchi, Y | 1 |
| Oguro, K | 1 |
| Sogabe, K | 1 |
| Hashimoto, H | 1 |
4 reviews available for alprenolol and Coronary Disease
| Article | Year |
|---|---|
Beta-adrenergic antagonists in the treatment of patients with heart disease.
Topics: Acebutolol; Adrenergic beta-Agonists; Alprenolol; Animals; Arrhythmias, Cardiac; Bronchial Spasm; Ca | 1981 |
Beta blocking agents: current status in the prevention of sudden coronary death.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Atenolol; Clinical Trials as Topic; Coronary D | 1982 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coron | 1984 |
[Long-term utilization of beta-blockers in arterial hypertension].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Blood Pressure; Coronary Disease; Drug Toleranc | 1978 |
5 trials available for alprenolol and Coronary Disease
| Article | Year |
|---|---|
Duration of action of beta blockers.
Topics: Adrenergic beta-Antagonists; Adult; Alprenolol; Atenolol; Blood Pressure; Coronary Disease; Heart Ra | 1980 |
Beta blocking agents: current status in the prevention of sudden coronary death.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Atenolol; Clinical Trials as Topic; Coronary D | 1982 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coron | 1984 |
Effect of long-term beta-blockade with alprenolol on platelet function and fibrinolytic activity in patients with coronary heart disease.
Topics: Adenosine Diphosphate; Adult; Aged; Alprenolol; Blood Platelets; Clinical Trials as Topic; Coronary | 1981 |
Letter: Beta blocker and blood viscosity.
Topics: Alprenolol; Blood Viscosity; Coronary Disease; Erythrocytes; Humans; Male; Middle Aged | 1976 |
9 other studies available for alprenolol and Coronary Disease
| Article | Year |
|---|---|
Effects of different beta adrenoceptor ligands in mice with permanent occlusion of the left anterior descending coronary artery.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Carbazoles; Carvedilol; Coronary Disease; Coronary | 2003 |
[Thrombocyte aggregation and fibrinolytic activity during long-term beta-block therapy].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Coronary Disease; Female; Fibrinolysis; Humans | 1982 |
Systolic time intervals during long-term beta-blockade with alprenol in ischaemic heart disease.
Topics: Aged; Alprenolol; Blood Pressure; Coronary Disease; Double-Blind Method; Drug Evaluation; Electrocar | 1983 |
Electrophysiological effects of alprenolol on depressed canine myocardium.
Topics: Action Potentials; Alprenolol; Animals; Coronary Disease; Dogs; Heart; Heart Ventricles; Purkinje Fi | 1980 |
Delay of onset of second degree pacemaker block by beta-blockade in patients with P-synchronous pacemakers.
Topics: Adult; Aged; Alprenolol; Coronary Disease; Exercise Test; Female; Heart Rate; Humans; Male; Middle A | 1981 |
The effect of beta-adrenoreceptive antagonists on the morbidity and mortality in cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Animals; Coronary Disease; Dogs; Follow-Up | 1976 |
Arrhythmia prophylaxis: Long-term suppressive medication.
Topics: Acute Disease; Aged; Alprenolol; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Coronary Diseas | 1975 |
Effect of beta-adrenergic blockade with alprenolol on ST-segment depression and circulatory dynamics during exercise in patients with effort angina.
Topics: Adult; Alprenolol; Angina Pectoris; Blood Pressure; Cardiac Output; Coronary Disease; Exercise Test; | 1976 |
Anti-arrhythmic effect of nadolol in experimental arrhythmias: comparison with propranolol and alprenolol.
Topics: Alprenolol; Anesthesia; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Dog | 1985 |